Target intelligence / Profile preview

MicroRNA-1271-5p (miR-1271-5p)

Target
miR-1271-5p
Molecular classification
Other (microRNA/microRNA family), Non-coding RNA, Epigenetic regulator
01

Overview

MicroRNA-1271-5p is a short, single-stranded RNA molecule (approx. 22 nucleotides) derived from the human miR-1271 precursor. It regulates the expression of multiple genes post-transcriptionally, generally by binding to complementary sites on target mRNAs leading to translational repression or mRNA degradation. miR-1271-5p is dysregulated in various cancer types, acting as a tumor suppressor or, in select contexts, as a tumor promoter. Its biological roles include regulation of cell proliferation, apoptosis, migration, and differentiation, often by controlling levels of key transcription factors and signaling proteins. In recent studies, altered miR-1271-5p expression is linked with both prognosis and therapeutic response in oncology, as well as with delayed bone healing.

Other names
miR-1271hsa-miR-1271-5pmicroRNA-1271
02

Mechanism of action

miR-1271-5p mimics: Suppress target gene(s), e.g., ZIC2, MYB, PTP4A1, ACY-1, and NOXA, leading to inhibition of proliferation, induction of apoptosis, suppression of migration/invasion, and impact on EMT in tumor cells. Antagomir/inhibitor: Prevents endogenous miR-1271-5p action, allowing its mRNA targets to escape repression, with opposite physiological effects.

03

Biological functions

Cell proliferationApoptosisCell migration/invasion/metastasis (particularly cancer)Epithelial-mesenchymal transition (EMT)Differentiation (osteogenesis and others)Signal transduction (by regulating key signaling pathways, e.g., PTP4A1/c-Src, MYB, ERK/TGF-β)
04

Disease associations

Cancer (breast, ovarian, pancreatic, colorectal, neuroblastoma, hepatocellular carcinoma, acute myeloid leukemia)Delayed bone healing/fracture repairPossibly other proliferative, degenerative, or regenerative diseases
05

Safety considerations

Off-target effects due to broad gene regulatory role of miRNAsDelivery challenges for miRNA mimics/inhibitors in vivoContext-dependent, tissue-dependent effects (may be tumor-suppressive or promoting depending on cancer type)No clinical drug safety data available
06

Interacting drugs

miR-1271-5p mimics

1 more in the full profile.

07

Biomarkers

miR-1271-5p (prognosis, diagnosis, or monitoring in breast, ovarian, hepatocellular, and colorectal cancers)miR-1271-5p (delayed fracture healing)

Beyond the preview

Go deeper on MicroRNA-1271-5p (miR-1271-5p).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA-1271-5p (miR-1271-5p).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call